PYXS
Pyxis Oncology, Inc.Company with tickers: PYXS
CIK
1782223
CUSIP
747324101
Shares Outstanding
63,355,482
13F Activity (30d)
49 filings
47 filers
Trades by corporate insiders — officers, directors and holders of more than 10% of the shares — disclosed to the SEC on Forms 3, 4 and 5. Form 4 must be filed within two business days of the trade.
| Date | Insider | Role | Type | Shares |
|---|---|---|---|---|
| 2026-03-24 | FLAVIN JOHN L |
Director | Award | 45,867 |
| 2026-03-24 | Wadhane Jitendra |
Prin Fin & Acct Officer | Award | 262,635 |
| 2026-03-24 | Wadhane Jitendra |
Prin Fin & Acct Officer | Award | 109,461 |
| 2026-03-24 | Cline Darren S |
Director | Award | 45,867 |
| 2026-03-24 | Metzger Michael A |
Director | Award | 45,867 |
| 2026-03-24 | HUMPHREY RACHEL |
Director | Award | 45,867 |
| 2026-03-24 | Lewis-Hall Freda C |
Director | Award | 45,867 |
| 2026-03-24 | Palani Santhosh |
Director | Award | 45,867 |
| 2026-03-24 | Dupont Jakob |
Director | Award | 45,867 |
| 2026-02-03 | Civik Thomas |
Director, Interim CEO | Award | 690,131 |
| 2025-04-21 | HUMPHREY RACHEL |
Director | Sell | 13,896 |
| 2025-04-17 | HUMPHREY RACHEL |
Director | Sell | 200 |
| 2025-04-14 | HUMPHREY RACHEL |
Director | Sell | 1,400 |
| 2025-03-31 | FLAVIN JOHN L |
Director | Award | 36,979 |
| 2025-03-31 | Civik Thomas |
Director, Interim CEO | Award | 36,979 |
| 2025-03-31 | Dupont Jakob |
Director | Award | 36,979 |
| 2025-03-31 | HUMPHREY RACHEL |
Director | Award | 36,979 |
| 2025-03-31 | Wadhane Jitendra |
Prin Fin & Acct Officer | Award | 263,782 |
| 2025-03-31 | Connealy Pamela Ann |
CFO & COO | Award | 414,163 |
| 2025-03-31 | Lewis-Hall Freda C |
Director | Award | 36,979 |
| 2025-03-31 | Cline Darren S |
Director | Award | 36,979 |
| 2025-03-31 | Palani Santhosh |
Director | Award | 36,979 |
| 2025-03-31 | Metzger Michael A |
Director | Award | 36,979 |
| 2025-03-31 | Sullivan Lara |
Director, President ,CEO & CMO | Award | 918,308 |
| 2024-12-23 | Sullivan Lara |
Director, President ,CEO & CMO | Award | 1,135,000 |
| 2024-12-23 | Wadhane Jitendra |
Prin Fin & Acct Officer | Award | 150,000 |
| 2024-12-23 | Connealy Pamela Ann |
CFO & COO | Award | 310,000 |
| 2024-11-26 | Connealy Pamela Ann |
CFO & COO | Buy | 5,450 |
| 2024-11-26 | Connealy Pamela Ann |
CFO & COO | Buy | 83,400 |
| 2024-06-10 | Metzger Michael A |
Director | Other | 0 |
| 2024-06-10 | Metzger Michael A |
Director | Award | 70,683 |
| 2024-06-07 | Palani Santhosh |
Director | Award | 6,000 |
| 2024-03-26 | Civik Thomas |
Director, Interim CEO | Award | 44,024 |
| 2024-03-26 | HUMPHREY RACHEL |
Director | Award | 38,741 |
| 2024-03-26 | Dupont Jakob |
Director | Award | 38,741 |
| 2024-03-26 | Wadhane Jitendra |
Prin Fin & Acct Officer | Award | 131,484 |
| 2024-03-26 | Sullivan Lara |
Director, President ,CEO & CMO | Award | 1,071,242 |
| 2024-03-26 | FLAVIN JOHN L |
Director | Award | 35,219 |
| 2024-03-26 | Lewis-Hall Freda C |
Director | Award | 35,219 |
| 2024-03-26 | Cline Darren S |
Director | Award | 35,219 |
| 2024-03-26 | Connealy Pamela Ann |
CFO & COO | Award | 328,710 |
| 2024-03-12 | Palani Santhosh |
Director | Other | 0 |
| 2024-03-12 | Palani Santhosh |
Director | Award | 69,760 |
| 2023-12-29 | Kobayashi Ken |
Chief Medical Officer | Award | 443,514 |
| 2023-12-29 | Kobayashi Ken |
Chief Medical Officer | Award | 110,878 |
| 2023-11-29 | Connealy Pamela Ann |
CFO & COO | Tax | 36,949 |
| 2023-11-27 | Kobayashi Ken |
Chief Medical Officer | Other | 0 |
| 2023-11-15 | Wadhane Jitendra |
Prin Fin & Acct Officer | Award | 40,000 |
| 2023-09-28 | Connealy Pamela Ann |
CFO & COO | Buy | 8,000 |
| 2023-09-27 | Wadhane Jitendra |
Prin Fin & Acct Officer | Buy | 2,500 |
Showing 1–50 of 169 transactions